Group B Streptococcal Neonatal Meningitis.

Area of Science:

• Neonatal infectious diseases
• Neuroscience
• Microbiology

Background:

• Neonatal bacterial meningitis, particularly GBS meningitis, leads to high mortality and neurological disability.
• Despite preventative measures, GBS meningitis incidence and morbidity remain unchanged since the 1970s.
• Understanding the mechanisms of GBS-induced brain injury is crucial for developing effective treatments.

Purpose of the Study:

• To provide an updated review of neonatal GBS meningitis.
• To discuss epidemiology, diagnosis, management, and pathogenic mechanisms.
• To explore experimental models for studying GBS meningitis.

Main Methods:

• Literature review of clinical data on neonatal GBS meningitis.
• Analysis of human evidence regarding disease mechanisms.
• Evaluation of experimental models used in GBS meningitis research.

Main Results:

• GBS is the leading cause of bacterial meningitis in infants under 90 days.
• Maternal GBS colonization is the primary risk factor for neonatal invasive disease.
• A significant number of survivors experience long-term neurological or neuropsychiatric sequelae.

Conclusions:

• Further research into GBS meningitis pathophysiology is essential.
• Development of novel therapeutic and neuroprotective strategies is urgently needed.
• Experimental models require careful consideration of their relevance to human disease.